September 20, 2024
Are new Alzheimer’s drugs the revolution doctors have been waiting for?
A doctor points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer’s Research and Treatment (CART) at Brigham And Women’s Hospital in Boston, Massachusetts, U.S., March 30, 2023. — Reuters Two new drugs, called ‘lecanemab’ and ‘donanemab’, are gaining significant attention as the former is capable of slowing the debilitating progression of Alzheimer’s disease. But while their defenders see them as a breakthrough in medical research, critics see them as another disappointment after a series of costly failures. “We’ve turned a corner” thanks to these treatments, said British biologist John Hardy, who has been studying Alzheimer’s


